TANG CAPITAL PARTNERS LP 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-26 4:00 pm Sale |
2023-12-26 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
TANG CAPITAL PARTNERS LP | 294,626 8.800% |
-38,374 (-11.52%) |
Filing |
| 2023-12-26 5:00 pm Purchase |
2023-11-14 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
TANG CAPITAL PARTNERS LP | 333,000 9.996% |
333,000 (New Position) |
Filing |